We are live on ! Find out more
DnB Asset Management

DnB Asset Management Portfolio holdings

AUM $28B
1-Year Est. Return 26%
This Fund
S&P 500
This Quarter Est. Return
+0.74%
1 Year Est. Return
+26%
3 Year Est. Return
+97.1%
5 Year Est. Return
+115.87%
10 Year Est. Return
+443.63%
AUM
$4.54B
AUM Growth
+$44.6M
Cap. Flow
+$40.9M
Cap. Flow %
0.9%
Top 10 Hldgs %
30.09%
Holding
489
New
23
Increased
211
Reduced
126
Closed
30

Top Buys

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$38.2M
2
BKNG icon
Booking.com
BKNG
+$33M
3
SNDK
SANDISK CORP
SNDK
+$32.4M
4
ORCL icon
Oracle
ORCL
+$31M
5
AET
Aetna Inc
AET
+$25.8M

Sector Composition

Rank Sector Weight
1 Technology 21.13%
2 Financials 15.34%
3 Healthcare 11.87%
4 Consumer Discretionary 9.13%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZTS icon
101
Zoetis
ZTS
$31.9B
$7.94M 0.18%
164,722
+6,400
+4% +$306K
BRK.B icon
102
Berkshire Hathaway Class B
BRK.B
$1.1T
$7.92M 0.17%
58,223
-1,286
-2% -$183K
RRX icon
103
Regal Rexnord
RRX
$13.5B
$7.71M 0.17%
106,167
+659
+0.6% +$50.9K
HD icon
104
Home Depot
HD
$332B
$7.7M 0.17%
69,255
+600
+0.9% +$67.2K
IQV icon
105
IQVIA
IQV
$39.1B
$7.67M 0.17%
105,700
+26,100
+33% +$1.79M
VIAV icon
106
Viavi Solutions
VIAV
$8.65B
$7.23M 0.16%
1,097,428
-153,115
-12% -$1.12M
AZO icon
107
AutoZone
AZO
$49.1B
$7.19M 0.16%
+10,776
New +$7.38M
SYK icon
108
Stryker
SYK
$133B
$7.19M 0.16%
75,195
+7,400
+11% +$701K
CVX icon
109
Chevron
CVX
$383B
$7.11M 0.16%
73,684
+28,800
+64% +$3.02M
HES
110
DELISTED
Hess
HES
$7.04M 0.16%
105,249
-8,270
-7% -$587K
TMO icon
111
Thermo Fisher Scientific
TMO
$214B
$6.97M 0.15%
53,693
+6,800
+15% +$886K
MOD icon
112
Modine Manufacturing
MOD
$10.3B
$6.9M 0.15%
642,502
+514,484
+402% +$6.15M
BAP icon
113
Credicorp
BAP
$32B
$6.79M 0.15%
48,882
-25,787
-35% -$3.77M
BIDU icon
114
Baidu
BIDU
$36.5B
$6.75M 0.15%
33,900
-82,100
-71% -$16.8M
OIIM
115
DELISTED
02Micro International
OIIM
$6.68M 0.15%
2,570,218
+38,000
+2% +$89.9K
MM
116
DELISTED
MILLENNIAL MEDIA INC COM STK (DE)
MM
$6.61M 0.15%
4,082,785
VRTX icon
117
Vertex Pharmaceuticals
VRTX
$122B
$6.43M 0.14%
52,090
+9,500
+22% +$1.2M
DAR icon
118
Darling Ingredients
DAR
$9.69B
$6.22M 0.14%
424,405
+156,900
+59% +$2.31M
HUM icon
119
Humana
HUM
$44B
$5.93M 0.13%
31,014
+14,700
+90% +$2.73M
AAP icon
120
Advance Auto Parts
AAP
$3.39B
$5.92M 0.13%
+37,190
New +$5.68M
VIAB
121
DELISTED
Viacom Inc. Class B
VIAB
$5.88M 0.13%
90,914
-38,600
-30% -$2.61M
ESRX
122
DELISTED
Express Scripts Holding Company
ESRX
$5.88M 0.13%
66,074
+18,100
+38% +$1.58M
VOYA icon
123
Voya Financial
VOYA
$9.09B
$5.85M 0.13%
125,900
+19,400
+18% +$874K
AMGN icon
124
Amgen
AMGN
$209B
$5.81M 0.13%
37,866
+800
+2% +$128K
SCHW
125
Charles Schwab
SCHW
$181B
$5.74M 0.13%
175,860
+26,100
+17% +$825K

Similar funds

DnB Asset Management's Q2 2015 Portfolio in Review

As of Q2 2015, DnB Asset Management held 489 positions worth $4.54B, up 0.99% from $4.49B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

DnB Asset Management's Q2 2015 filing shows 23 new, 211 increased, 126 reduced and 30 closed positions. Its largest new stake was AutoZone: 10,776 shares worth $7.19M. The largest sale was Citrix Systems Inc, an estimated $64M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

  • DnB Asset Management's largest Q2 2015 buy was AutoZone: 10,776 shares worth $7.19M.
  • DnB Asset Management added most to Bank of America in Q2 2015, an estimated $38.2M increase.
  • DnB Asset Management's biggest Q2 2015 reduction was AbbVie, cutting an estimated $53.3M.
  • DnB Asset Management fully exited Citrix Systems Inc in Q2 2015, selling an estimated $64M.
  • DnB Asset Management's ten largest holdings make up 30% of its $4.54B portfolio in Q2 2015.
  • DnB Asset Management opened 23 new positions and closed 30 in Q2 2015.
  • DnB Asset Management's portfolio value rose 0.99% quarter-over-quarter to $4.54B.

Based on DnB Asset Management's 13F filing for Q2 2015, filed 7 Jul 2015.